Literature DB >> 24827969

Effectiveness of recombinant human bone morphogenetic protein-7 in the management of congenital pseudoarthrosis of the tibia: a randomised controlled trial.

Sakti Prasad Das1, Shankar Ganesh, Sudhakar Pradhan, Deepak Singh, Ram Narayan Mohanty.   

Abstract

PURPOSE: Despite the popularity and an increased use of bone morphogenetic protein to improve bone healing in patients with congenital pseudoarthrosis of the tibia (CPT), no previous study has compared its efficacy against any other procedure.
METHODS: We randomised 20 consecutive patients (mean age 4.1 years) with CPT (Crawford type IV) associated with neurofibromatosis type 1(NF1) and no previous history of surgery into two groups. Group 1 received recombinant human bone morphogenetic protein-7 (rhBMP-7) along with intramedullary Kirschner (K)-wire fixation and autologous bone grafting; group 2 received only K wire and grafting. Outcome measures were time to achieve union, Johnston grade, tibial length and the American Orthopaedic Foot and Ankle Society (AOFAS) score, which were evaluated preoperatively and at five year follow-up.
RESULTS: Study results showed that patients in group 1 achieved primary bone union at a mean of 14.5 months [standard error (SE) 5.2], whereas group 2 took a mean of 17.11 months (SE 5.0). However, the log-rank test showed no difference in healing times between groups at all time points (P = 0.636). There was a statistically significant pre- to post operative improvement (P < 0.05) within groups for the other outcome measures.
CONCLUSION: In a five year follow-up, these results suggest that rh-BMP-7 and autologous bone grafting is no better than autologous grafting alone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24827969     DOI: 10.1007/s00264-014-2361-7

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  39 in total

Review 1.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Authors:  D H Gutmann; A Aylsworth; J C Carey; B Korf; J Marks; R E Pyeritz; A Rubenstein; D Viskochil
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

2.  The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series.

Authors:  B Stephens Richards; Matthew E Oetgen; Charles E Johnston
Journal:  J Bone Joint Surg Am       Date:  2010-01       Impact factor: 5.284

3.  Neurofibromatosis in the pediatric patient.

Authors:  A H Crawford
Journal:  Orthop Clin North Am       Date:  1978-01       Impact factor: 2.472

4.  Congenital pseudarthrosis of the tibia: a retrospective review.

Authors:  J A Traub; W O'Connor; P D Masso
Journal:  J Pediatr Orthop       Date:  1999 Nov-Dec       Impact factor: 2.324

5.  Donor site morbidity following the harvesting of cortical bone graft from the tibia in children.

Authors:  Siddesh N Dodabassappa; Hitesh H Shah; Benjamin Joseph
Journal:  J Child Orthop       Date:  2010-08-10       Impact factor: 1.548

6.  Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report.

Authors:  Darko Anticevic; Mislav Jelic; Slobodan Vukicevic
Journal:  J Pediatr Orthop B       Date:  2006-05       Impact factor: 1.041

7.  Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS).

Authors:  F Grill; G Bollini; P Dungl; J Fixsen; F Hefti; E Ippolito; B Romanus; C Tudisco; S Wientroub
Journal:  J Pediatr Orthop B       Date:  2000-04       Impact factor: 1.041

Review 8.  Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion.

Authors:  Andrew P White; Alexander R Vaccaro; Jeremy A Hall; Peter G Whang; Brian C Friel; Michael D McKee
Journal:  Int Orthop       Date:  2007-07-25       Impact factor: 3.075

9.  Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience.

Authors:  Bruno Dohin; Noémi Dahan-Oliel; François Fassier; Reggie Hamdy
Journal:  Clin Orthop Relat Res       Date:  2009-07-09       Impact factor: 4.176

10.  Orthopaedic manifestations of neurofibromatosis in children: an update.

Authors:  Michael G Vitale; Abhijit Guha; David L Skaggs
Journal:  Clin Orthop Relat Res       Date:  2002-08       Impact factor: 4.176

View more
  12 in total

1.  Bone morphogenetic protein-2 for the treatment of congenital pseudarthrosis of the tibia or persistent tibial nonunion in children and adolescents: A retrospective study with a minimum 2-year follow-up.

Authors:  Tim N Hissnauer; Norbert Stiel; Kornelia Babin; Martin Rupprecht; Michael Hoffmann; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal:  J Mater Sci Mater Med       Date:  2017-02-17       Impact factor: 3.896

2.  Is ceramics an appropriate bone morphogenetic protein delivery system for clinical use?

Authors:  Slobodan Vukicevic; Nikola Stokovic; Marko Pecina
Journal:  Int Orthop       Date:  2019-03-15       Impact factor: 3.075

3.  Clinical need for bone morphogenetic proteins.

Authors:  Slobodan Vukičević; Lovorka Grgurević; Marko Pećina
Journal:  Int Orthop       Date:  2017-06-29       Impact factor: 3.075

4.  Marshall R. Urist and the discovery of bone morphogenetic proteins.

Authors:  Lovorka Grgurevic; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2017-02-11       Impact factor: 3.075

5.  Tissue engineering and regenerative orthopaedics (TERO).

Authors:  Marko Pećina; Slobodan Vukičević
Journal:  Int Orthop       Date:  2014-08-12       Impact factor: 3.075

6.  "Bone Morphogenic Protein augmentation for long bone healing" response to "Clinical need for bone morphogenetic protein".

Authors:  Gopal Shankar Krishnakumar; Alice Roffi; Davide Reale; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2017-09-03       Impact factor: 3.075

7.  Relationship between postoperative complications and fibular integrity in congenital pseudarthrosis of the tibia in children.

Authors:  Yao-Xi Liu; Hai-Bo Mei; Guang-Hui Zhu; Rong-Guo He; Kun Liu; Jin Tang; Jiang-Yan Wu; Wei-Hua Ye; Xin Hu; Qian Tan; An Yan; Sheng-Xiang Huang; Xiao-Qian Tan; Ting Lei
Journal:  World J Pediatr       Date:  2016-12-23       Impact factor: 2.764

Review 8.  The role of growth factors in stem cell-directed chondrogenesis: a real hope for damaged cartilage regeneration.

Authors:  Ewelina Augustyniak; Tomasz Trzeciak; Magdalena Richter; Jacek Kaczmarczyk; Wiktoria Suchorska
Journal:  Int Orthop       Date:  2014-12-16       Impact factor: 3.075

Review 9.  Biological aspects of segmental bone defects management.

Authors:  Ivo Dumic-Cule; Marko Pecina; Mislav Jelic; Morana Jankolija; Irena Popek; Lovorka Grgurevic; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2015-03-17       Impact factor: 3.075

10.  Management of congenital pseudarthrosis of the tibia with the Ilizarov method in a paediatric population: influence of aetiological factors.

Authors:  Dmitry Y Borzunov; Alexander Y Chevardin; Alexander I Mitrofanov
Journal:  Int Orthop       Date:  2015-11-07       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.